CXCL8 and ischemia: Since the effect of preventing immune infiltration and muscle degeneration was reduced in the IL8-silenced FECS-Ad injected group compared to the FECS-Ad injected group, it is suggested that IL8 may play a role in preventing immune infiltration and muscle degeneration after ischemia in the hindlimb.